Write For Us

Data shows drug slowing Alzheimer’s but doubts over effect remain

Sponsored Post Vitamin D2 Canada Persia
39 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Experts have welcomed full data showing an experimental drug can slow cognitive decline in Alzheimer’s patients, but warned improvements were comparatively small and said it remained unclear how much difference it might make in people’s lives.
Japanese drugmaker Eisai and its United States partner Biogen announced in September that preliminary data from a trial of lecanemab found it slowed cognitive decline by 27 percent across 18 months.
the companies on Tuesday provided the full results of the study on nearly 1,800 people in the earliest stages of the disease, the most common cause of dementia among older adults.

Al Jazeera’s Harry Fawcett reports from London.

Subscribe to our channel: http://bit.ly/AJSubscribe
Follow us on Twitter: https://twitter.com/AJEnglish
Find us on Facebook: https://www.facebook.com/aljazeera
Check our website: http://www.aljazeera.com/
Check out our Instagram page: https://www.instagram.com/aljazeeraenglish/

#Alzheimers #lecanemab #Biogen #Eisai
Category
World
Tags
Aducanumab, Aljazeera, Alzheimer disease
Sign in or sign up to post comments.
Be the first to comment